
Six Mistakes That Can Impact Your HPV Assay Validation
Discover six common HPV assay validation mistakes, from sample selection and cut-off optimisation to population differences and platform changes.
Read moreExpert guidance across pharma, biotech, and medical devices — stay ahead of industry trends and best practices.

Discover six common HPV assay validation mistakes, from sample selection and cut-off optimisation to population differences and platform changes.
Read more
Can one HPV clinical performance study support both IVDR and WHO Prequalification? Learn how to align requirements and avoid duplicate studies.
Read more
Explore the Meijer criteria for HPV assay validation, including clinical sensitivity, specificity, reproducibility and their role in IVDR and WHO PQ.
Read more
Discover why combined-study site agreements need explicit IVDR monitoring and audit rights for test sites and sample collection sites.
Read more
Learn why CDx clinical trial and IVDR performance study submissions must align while remaining independently complete for different regulatory reviewers.
Read more
Who holds IVDR sponsorship in a CDx performance study? Learn why sponsor roles, delegation and governance must be defined early in combined studies.
Read more
Discover why oncology IVD clinical performance studies often fail beyond regulatory approval, and how better study design supports reimbursement and clinical adoption.
Read more
For founders, CSOs, and regulatory leads at oncology IVD companies operating in fast-evolving biomarker landscapes.
Read more
Learn why the intended purpose statement is the most important strategic decision in oncology IVD development and how it shapes regulatory approval, clinical evidence, reimbursement, and adoption.
Read more
Not every CRO is equipped for IVD performance studies. Learn the nine capabilities that matter most for compliant, defensible evidence generation.
Read more
Explore the three main sponsorship models for combined IVD-drug studies and learn how governance structures impact compliance, timelines, and data ownership.
Read more
Understand the difference between delegating operational tasks and transferring Sponsor responsibilities in IVD performance studies under IVDR and FDA frameworks.
Read more
Learn who carries Sponsor responsibility in IVD performance studies and why this role shapes compliance, data ownership, and regulatory success.
Read more